Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan s hows anticancer activity[1]. 1 * 1 mg
Catalog # MDEXHY-132254
Supplier: MEDCHEMEXPRESS
Frequently Bought Together